Inequitable vaccine distribution during the COVID-19 pandemic, particularly in low- and lower- middle income countries, has shown how market failures have hampered access to medical technologies. This brief identifies governance, financing, and regulation problems at the state, regional, and global levels that contribute to the market failure of medical technologies. The G20 is a viable avenue to find shared, effective solutions to encourage governments in adopting market-shaping strategies to meet the common objective of equitable access to medical technologies. Investing in research and development and expanding manufacturing facilities located in different regions worldwide are essential for the realisation of the common objective. Under the direction of a global governing entity and with allocations of funding and supportive regulations, these manufacturing facilities can serve as a pathway to sustain the production and distribution of medical technologies.
Register for Updates
Would you like to receive updates on the Global Solutions Initiative, upcoming events, G7 and G20-related developments and the future of multilateralism? Then subscribe here!
1 You hereby agree that the personal data provided may be used for the purpose of updates on the Global Solutions Initiative by the Global Solutions Initiative Foundation gemeinnützige GmbH. Your consent is revocable at any time (by e-mail to [email protected] or to the contact data given in the imprint). The update is sent in accordance with the privacy policy and to advertise the Global Solutions Initiative’s own products and services.